Literature DB >> 20625756

CHMP2B mutations are rare in French families with frontotemporal lobar degeneration.

Mustapha Ghanim1, Léna Guillot-Noel, Florence Pasquier, Ludmila Jornea, Vincent Deramecourt, Bruno Dubois, Isabelle Le Ber, Alexis Brice.   

Abstract

Two C-truncating CHMP2B (chromatin modifying protein 2B) mutations were recently found in Danish and Belgian families with autosomal dominant forms of frontotemporal lobar degeneration (FTLD). In addition, few CHMP2B missense mutations of uncertain pathogenic role were reported in several families with FTLD or FTLD associated with motoneuron disease (FTLD-MND). In order to determine the genetic contribution of CHMP2B mutations in FTLD and FTLD-MND families, we analyzed the CHMP2B gene in 198 French probands with familial FTLD and FTLD-MND. One CHMP2B missense variant was found in a proband with familial FTLD (0.8%). The pathogenic role of CHMP2B missense variants is unclear, however the pSer194Leu substitution, located in the C-terminal domain of the protein, was predicted to alter the stability of the protein by in silico analyses. We conclude that CHMP2B mutations represent a rare cause of familial FTLD and they are not implicated in familial FTLD-MND in French patients. The previously reported C-truncating CHMP2B mutations may be private to the Danish and Belgian pedigrees.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20625756     DOI: 10.1007/s00415-010-5655-8

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  20 in total

Review 1.  El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis.

Authors:  B R Brooks; R G Miller; M Swash; T L Munsat
Journal:  Amyotroph Lateral Scler Other Motor Neuron Disord       Date:  2000-12

Review 2.  Frontotemporal dementia.

Authors:  David Neary; Julie Snowden; David Mann
Journal:  Lancet Neurol       Date:  2005-11       Impact factor: 44.182

3.  Release of autoinhibition converts ESCRT-III components into potent inhibitors of HIV-1 budding.

Authors:  Alessia Zamborlini; Yoshiko Usami; Sheli R Radoshitzky; Elena Popova; Giorgio Palu; Heinrich Göttlinger
Journal:  Proc Natl Acad Sci U S A       Date:  2006-12-04       Impact factor: 11.205

Review 4.  Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria.

Authors:  D Neary; J S Snowden; L Gustafson; U Passant; D Stuss; S Black; M Freedman; A Kertesz; P H Robert; M Albert; K Boone; B L Miller; J Cummings; D F Benson
Journal:  Neurology       Date:  1998-12       Impact factor: 9.910

5.  Mutations in the endosomal ESCRTIII-complex subunit CHMP2B in frontotemporal dementia.

Authors:  Gaia Skibinski; Nicholas J Parkinson; Jeremy M Brown; Lisa Chakrabarti; Sarah L Lloyd; Holger Hummerich; Jørgen E Nielsen; John R Hodges; Maria Grazia Spillantini; Tove Thusgaard; Sebastian Brandner; Arne Brun; Martin N Rossor; Anders Gade; Peter Johannsen; Sven Asger Sørensen; Susanne Gydesen; Elizabeth M C Fisher; John Collinge
Journal:  Nat Genet       Date:  2005-07-24       Impact factor: 38.330

Review 6.  Endosome function and dysfunction in Alzheimer's disease and other neurodegenerative diseases.

Authors:  Ralph A Nixon
Journal:  Neurobiol Aging       Date:  2005-03       Impact factor: 4.673

7.  CHMP2B C-truncating mutations in frontotemporal lobar degeneration are associated with an aberrant endosomal phenotype in vitro.

Authors:  Julie van der Zee; Hazel Urwin; Sebastiaan Engelborghs; Marc Bruyland; Rik Vandenberghe; Bart Dermaut; Tim De Pooter; Karin Peeters; Patrick Santens; Peter P De Deyn; Elizabeth M Fisher; John Collinge; Adrian M Isaacs; Christine Van Broeckhoven
Journal:  Hum Mol Genet       Date:  2007-10-22       Impact factor: 6.150

8.  ESCRT-III recognition by VPS4 ATPases.

Authors:  Melissa D Stuchell-Brereton; Jack J Skalicky; Collin Kieffer; Mary Anne Karren; Sanaz Ghaffarian; Wesley I Sundquist
Journal:  Nature       Date:  2007-10-11       Impact factor: 49.962

9.  Genetic variability in CHMP2B and frontotemporal dementia.

Authors:  Parastoo Momeni; Ekaterina Rogaeva; Vivianna Van Deerlin; Wuxing Yuan; Jordan Grafman; Michael Tierney; Edward Huey; Jason Bell; Chris M Morris; Rajesh N Kalaria; Susan J van Rensburg; Dana Niehaus; Felix Potocnik; Toshitaka Kawarai; Shabnam Salehi-Rad; Christine Sato; Peter St George-Hyslop; John Hardy
Journal:  Neurodegener Dis       Date:  2006       Impact factor: 2.977

10.  ALS phenotypes with mutations in CHMP2B (charged multivesicular body protein 2B).

Authors:  N Parkinson; P G Ince; M O Smith; R Highley; G Skibinski; P M Andersen; K E Morrison; H S Pall; O Hardiman; J Collinge; P J Shaw; E M C Fisher
Journal:  Neurology       Date:  2006-06-28       Impact factor: 9.910

View more
  13 in total

Review 1.  Clinical aspects of familial forms of frontotemporal dementia associated with parkinsonism.

Authors:  Shinsuke Fujioka; Zbigniew K Wszolek
Journal:  J Mol Neurosci       Date:  2011-06-08       Impact factor: 3.444

Review 2.  Clinical neurogenetics: recent advances.

Authors:  Davide Pareyson; Ettore Salsano
Journal:  J Neurol       Date:  2012-07-21       Impact factor: 4.849

Review 3.  Dementia and behavioral neurology: recent advances.

Authors:  Basar Bilgic; Hasmet A Hanagasi; Murat Emre
Journal:  J Neurol       Date:  2012-04-18       Impact factor: 4.849

Review 4.  Frontotemporal dementia: from Mendelian genetics towards genome wide association studies.

Authors:  Raffaele Ferrari; John Hardy; Parastoo Momeni
Journal:  J Mol Neurosci       Date:  2011-09-06       Impact factor: 3.444

Review 5.  Modelling amyotrophic lateral sclerosis in rodents.

Authors:  Tiffany W Todd; Leonard Petrucelli
Journal:  Nat Rev Neurosci       Date:  2022-03-08       Impact factor: 34.870

Review 6.  Parkinsonian syndrome in familial frontotemporal dementia.

Authors:  Joanna Siuda; Shinsuke Fujioka; Zbigniew K Wszolek
Journal:  Parkinsonism Relat Disord       Date:  2014-06-13       Impact factor: 4.891

Review 7.  The role of CHMP2BIntron5 in autophagy and frontotemporal dementia.

Authors:  Christopher S Krasniak; S Tariq Ahmad
Journal:  Brain Res       Date:  2016-03-10       Impact factor: 3.252

8.  Potential contribution of exosomes to the prion-like propagation of lesions in Alzheimer's disease.

Authors:  Valérie Vingtdeux; Nicolas Sergeant; Luc Buée
Journal:  Front Physiol       Date:  2012-07-05       Impact factor: 4.566

9.  Genetic overlap between apparently sporadic motor neuron diseases.

Authors:  Marka van Blitterswijk; Lotte Vlam; Michael A van Es; W-Ludo van der Pol; Eric A M Hennekam; Dennis Dooijes; Helenius J Schelhaas; Anneke J van der Kooi; Marianne de Visser; Jan H Veldink; Leonard H van den Berg
Journal:  PLoS One       Date:  2012-11-14       Impact factor: 3.240

10.  Population-specific regulation of Chmp2b by Lbx1 during onset of synaptogenesis in lateral association interneurons.

Authors:  Jun Xu; Mariko Nonogaki; Ravi Madhira; Hsiao-Yen Ma; Ola Hermanson; Chrissa Kioussi; Michael K Gross
Journal:  PLoS One       Date:  2012-12-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.